EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome
Publication date: Available online 20 April 2021Source: Journal of Pharmacological SciencesAuthor(s): Tsukasa Nozu, Saori Miyagishi, Rintaro Nozu, Masatomo Ishioh, Kaoru Takakusaki, Toshikatsu Okumura
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Irritable Bowel Syndrome